Provided by Tiger Trade Technology Pte. Ltd.

Agenus

8.33
-1.6000-16.11%
Post-market: 8.480.1453+1.74%17:51 EDT
Volume:1.95M
Turnover:17.56M
Market Cap:375.02M
PE:3.33
High:9.99
Open:9.95
Low:8.28
Close:9.93
52wk High:10.31
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:1.40
T/O Rate:4.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-1.88
PE(LYR):-2,452.89

Loading ...

Agenus Reports Landmark Bot+bal Data Showing 33% Three-year Overall Survival in Refractory Mss Metastatic Colorectal Cancer Without Active Liver Metastases at Esmo Gi 2026

THOMSON REUTERS
·
Jul 06

Agenus to Present Three-year Survival Data from Bot+bal Phase 1b Study in MSS Metastatic Colorectal Cancer at ESMO GI 2026

Reuters
·
Jun 25

Agenus Shareholders Approve Governance, Compensation and Auditors

TIPRANKS
·
Jun 23

Agenus shareholders approve 5 million-share increase to 2019 equity plan at annual meeting

Reuters
·
Jun 23

Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion

TIPRANKS
·
Jun 12

Agenus announces virtual annual shareholders meeting

Reuters
·
Jun 03

Backlash over Trump's $1.776 billion fund tests Blanche's bid for US attorney general

Reuters
·
May 29

Agenus reports Phase 2 BOT+BAL melanoma trial shows 22% response rate

Reuters
·
May 22

Agenus says AI model predicts BOT+BAL response, survival in MSS metastatic colorectal cancer

Reuters
·
May 22

Agenus Announces Resignation of Principal Accounting Officer

TIPRANKS
·
May 16

Agenus announces publication of Phase 1b BOT+BAL data

TIPRANKS
·
May 16

Agenus principal accounting officer Charette resigns effective May 29

Reuters
·
May 16

Agenus reports Phase 1b BOT+BAL trial shows 17% response in post-immunotherapy HCC

Reuters
·
May 16

MiNK Therapeutics Q1 FY26 net loss narrows to $2.74 million

Reuters
·
May 15

Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained

TIPRANKS
·
May 12

Agenus Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Agenus reports Q1 revenue $33.7M vs. $24.1M last year

TIPRANKS
·
May 11

Agenus provides 2026 strategic priorities

TIPRANKS
·
May 11

Agenus announces conclusion of SEC investigation with no enforcement action

TIPRANKS
·
May 11

Agenus Q1 Sales $33.700M May Not Be Comparable To $129.500M Estimate, Net Income Of $39.2M Vs. Loss of $26.4M YoY

Benzinga Earnings
·
May 11